IL6 and leishmaniasis: This work opens new venues for developing new chemotherapy for leishmaniasis based on BSF2 or derivatives and highlights the dual transcriptome as a valuable phenotypic assay tool to investigate host-parasite interactions for antileishmanial drug discovery.